Free Trial

Ambu A/S (OTCMKTS:AMBBY) Shares Down 0.9% - Should You Sell?

Ambu A/S logo with Medical background

Ambu A/S (OTCMKTS:AMBBY - Get Free Report)'s share price fell 0.9% on Monday . The stock traded as low as $18.28 and last traded at $18.28. 250 shares were traded during mid-day trading, a decline of 65% from the average session volume of 708 shares. The stock had previously closed at $18.45.

Ambu A/S Price Performance

The company has a debt-to-equity ratio of 0.09, a current ratio of 2.52 and a quick ratio of 1.51. The company has a market capitalization of $4.30 billion and a price-to-earnings ratio of 91.40. The business has a fifty day moving average price of $19.79 and a 200 day moving average price of $18.90.

Ambu A/S (OTCMKTS:AMBBY - Get Free Report) last issued its quarterly earnings results on Friday, August 30th. The company reported $0.07 earnings per share for the quarter. Ambu A/S had a return on equity of 8.09% and a net margin of 8.55%. The business had revenue of $199.56 million for the quarter.

About Ambu A/S

(Get Free Report)

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

See Also

Should you invest $1,000 in Ambu A/S right now?

Before you consider Ambu A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambu A/S wasn't on the list.

While Ambu A/S currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Market Volatility: Election Season Strategies for Investors
Meta Platforms Tops Most Upgraded Stocks List—Here’s What to Expect
Alphabet Gaining Momentum: Can It Reach $200 by December?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines